Secondary Analyses


Below is a summary of completed, in progress, and planned secondary analyses for the VICTORIA study.

Analyses Status
(Completed, In Progress, Planned)
Related Links
Contextual with other trials Completed Circulation publication
Impact of natriuretic peptides on
result and their evolution
Completed JACC FF publication
HFA 20 presentation
Index admission groups Completed JAMACardiol. publication
Anemia Completed Circulation publication
Baseline changes in renal function Completed Eur J Heart Fail. publication
Sequential natriuretic peptides
and outcomes
Completed JACC HF publication
HFA 21 presentation
Atrial fibrillation Completed Eur J Heart Fail publication
HFA 21 presentation
Safety/hypotension/syncope/
BP response
Completed JAHA publication
HFA 21 presentation
CAD/non CAD Completed Eur J Heart Fail publication
ACC 21 presentation
Sacubitril/valsartan baseline/
drop ins
Completed Eur J Heart Fail publication
ECHO 1 paired data & Rx effect Completed Eur J Heart Fail publication
HFA 20 presentation
Biomarkers Completed J Card Fail publication
ACC 21 presentation
Health economics Completed Circulation publication
NA registry Completed Circ Heart Fail publication
HFSA 20 presentation
NA Registry – GDMT Completed J Card Fail publication
HFSA 20 presentation
PK/PD & PK adherence Completed Clin Pharmacol Ther publication
QoL as an outcome/predictor Completed Circ Heart Fail publication
Sex/Age Completed JACC Heart Fail publication
Screening NT-proBNP Completed Circ Heart Fail publication
ECG parameters Completed Eur J Heart Fail publication
Standard of care Completed Circ Heart Fail publication
HFSA 2020 presentation
Prognostic model Completed J Card Fail publication
HFA 21 presentation
LVEF stratification Completed JACC Heart Fail publication
Diabetes In Progress  
Recurrent events In Progress  
Geographic variation In Progress  
Expanded endpoints In Progress  
ECHO 2: remodeling In Progress